Market Cap : 38.61 B | Enterprise Value : 39.59 B | PE Ratio : 53.42 | PB Ratio : 3.55 |
---|
NAS:ILMN has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:ILMN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Illumina's PE Ratio without NRI is 53.42. Illumina's 5-Year EBITDA growth rate is 6.30%. Therefore, Illumina's PEG Ratio for today is 8.48.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Illumina's PEG Ratio or its related term are showing as below:
During the past 13 years, Illumina's highest PEG Ratio was 62.79. The lowest was 0.67. And the median was 2.53.
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
The historical data trend for Illumina's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Illumina's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Diagnostics & Research industry and Healthcare sector, Illumina's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Illumina's PEG Ratio falls into.
PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.
Illumina's PEG Ratio for today is calculated as
PEG Ratio | = | PE Ratio without NRI | / | 5-Year EBITDA Growth Rate* |
= | 53.421739130435 | / | 6.30 | |
= | 8.48 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Thank you for viewing the detailed overview of Illumina's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Flatley Jay T | director | 9885 TOWNE CENTRE DR SAN DIEGO CA 92121 |
Tousi Susan H | officer: SVP Product Development | 5200 ILLUMINA WAY SAN DIEGO CA 92122 |
Reeves Kathryne Gambrell | officer: SVP, Chief Marketing Officer | 5200 ILLUMINA WAY SAN DIEGO CA 92122 |
Goswami Joydeep | officer: SVP Corp Business Development | SUMITOMO FUDOSAN MITA TWIN BLDG EAST WING 4-2-8 SHIBAURA MINATO-KU TOKYO M0 1080023 |
Dadswell Charles | officer: SVP & General Counsel | 5200 ILLUMINA WAY SAN DIEGO CA 92122 |
Desouza Francis A | director, officer: President and CEO | 350 ELLIS STREET MOUNTAIN VIEW CA 94043 |
Van Oene Mark | officer: SVP Chief Commercial Officer | 5200 ILLUMINA WAY SAN DIEGO CA 92122 |
Ragusa Robert P | officer: SVP, Global Quality & Ops | PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> Ownership Information: RAGUSA ROBERT P a.header:link {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:visited {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:hover {color: #191970;} |
Mcginnis Karen K | officer: VP, Chief Accounting Officer | INSIGHT ENTERPRISES INC 1305 WEST AUTO DRIVE TEMPE AZ 85284 |
Hoyt Aimee L | officer: SVP, Chief People Officer | 5200 ILLUMINA WAY SAN DIEGO CA 92122 |
Ronaghi Mostafa | officer: SVP, Entrepreneurial Devlopmt | 9885 TOWNE CENTRE DRIVE SAN DIEGO CA 92121 |
Aravanis Alexander | officer: SVP, Chief Technology Officer | 5200 ILLUMINA WAY SAN DIEGO CA 92122 |
Siegel Susan E | director | 3000 SAND HILL ROAD BLDG 3 STE 290 MENLO PARK CA 94025 |
Thompson John Wendell | director | C/O MICROSOFT CORPORATION ONE MICROSOFT WAY REDMOND WA 98053 |
Epstein Robert S | director | PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> Ownership Information: EPSTEIN ROBERT S a.header:link {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:visited {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:hover {color: #191970;} |
From GuruFocus
Other Sources
By Zacks 2022-01-12
By Zacks 2022-03-01
By Zacks 2022-02-18
By Zacks 2022-01-05
By Zacks 2022-03-14
By Zacks 2022-01-13
By tipranks.com 2022-03-02
By Fool 2022-01-11
By Fool 2022-01-22
By Zacks 2022-01-07
By Fool 2022-01-11
By Zacks 2021-12-27
By Zacks 2022-03-18
By Zacks 2022-02-11
By Seekingalpha 2022-03-07